An aggressive lactotroph pituitary tumor in a young male: A pituitary carcinoma without metastasis
- 16 May 2022
- journal article
- research article
- Published by Dustri-Verlgag Dr. Karl Feistle in Clinical Neuropathology
- Vol. 41 (5), 211-218
- https://doi.org/10.5414/np301458
Abstract
This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initially with bitemporal hemianopsia and slightly elevated prolactin. On magnetic resonance imaging of the brain, there was a sellar mass with parasellar invasion to the lateral aspects of the internal carotid arteries, compressing the optic chiasm. On histopathological analysis, the diagnosis was made of a densely granulated lactotroph pituitary tumor with a Ki67 proliferation rate of 15%, a mitotic count of 6/10 high-power fields, and p53 positivity. Based on these features, the tumor was classified as a grade 2b tumor according to the Trouillas classification, and a more aggressive behavior of the tumor could be expected. In order to anticipate a future need for alternative drug treatments, the following analyses were undertaken: MGMT methylation (present) as well as the expression of estrogen receptor (negative), programmeddeath ligand 1 (60 - 70% positive tumor cells), vascular endothelial growth factor-A and somatostatin receptor 2 (both positive). There was regrowth of residual tumor tissue, and the treatment consisted thus far of repeat surgery, cabergoline, pasireotide, and radiotherapy. Chemotherapy with temozolomide could not yet be initiated due to a concurrent infertility treatment. This case is unique because the tumor displays atypical characteristics, both in terms of morphology and behavior. It also illustrates how pathologists can play an important role in determining the diagnosis, prognosis, and possibilities for targeted therapy.Keywords
This publication has 26 references indexed in Scilit:
- Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growthActa Endocrinologica, 2015
- Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classificationJournal of Neurosurgery, 2015
- Aggressive Pituitary TumorsNeuroendocrinology, 2015
- The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapyJournal of Experimental & Clinical Cancer Research, 2014
- In Search of a Prognostic Classification of Endocrine Pituitary TumorsEndocrine Pathology, 2014
- Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodiesHuman Pathology, 2014
- Pituitary Carcinoma in SituEndocrine Practice, 2013
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-upActa Neuropathologica, 2013
- Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient managementPituitary, 2012
- Treatment of hyperprolactinemia: a systematic review and meta-analysisSystematic Reviews, 2012